Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
…, M Masilela, S McKenzie, K Molapo… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa
…, M Masenya, M Masilela, S McKenzie, K Molapo… - MedRxiv, 2021 - medrxiv.org
Background Assessing safety and efficacy of Covid-19 vaccines in different populations is
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …
Politics of Belonging in South Africa Since 2008
IK Ekanade - 2021 - univendspace.univen.ac.za
… RR Molapo, my initial promoter, you were more than a supervisor to me; it was a fatherson
relationship. Kea leboga nthate, MODIMO a le tshegofatse. My main Promoter, Dr P. …
relationship. Kea leboga nthate, MODIMO a le tshegofatse. My main Promoter, Dr P. …
[HTML][HTML] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a …
Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa …
Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …
Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
The emergence of SARS-CoV-2 Variants of Concern (VOCs) with mutations in key neutralizing
antibody epitopes threatens to undermine vaccines developed against the pandemic …
antibody epitopes threatens to undermine vaccines developed against the pandemic …
[BOOK][B] Kinetics of Single-Strand RNA Virus Entry and Transmission
BA Catching - 2022 - search.proquest.com
Pandemic Potential Pathogens remain an ever-present scourge upon the human species.
Epidemics and pandemics have ranged from nuances to having the power to shut the entire …
Epidemics and pandemics have ranged from nuances to having the power to shut the entire …
Vaccine Cocktail as a Future to Fight Against Family of SARS-Cov-19
D Sharma, N Sharotri, K Suvardhan, S Thakur - 2022 - preprints.org
Severe Acute Respiratory Syndrome Coronavirus 2 commonly known as SARS-CoV-2 is the
utmost challenging pandemic that attracted scientific community to discover therapeutics as …
utmost challenging pandemic that attracted scientific community to discover therapeutics as …
Structural and Biochemical Characterization of Proteins Relevant to Human Disease
R Boyd - 2021 - search.proquest.com
This work comprises a cumulative effort to provide analysis of proteins relevant to understanding
and treating human disease. This dissertation focuses on two main protein complexes: …
and treating human disease. This dissertation focuses on two main protein complexes: …
[CITATION][C] Urban poverty reduction through municipal solid waste management (MSWM): a case study of Maseru and Maputsoe in Lesotho.
GGK Mvuma - 2002
